Research Partnership has published a new Living with Chronic Pain market report for 2016
Research Partnership has published a new Living with Chronic Pain market report for 2016.
Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients with diabetic neuropathic pain, chronic lower back pain, cancer pain and headache/migraine pain. At least 60% of the patients surveyed are currently prescribed long acting opioids (LAOs). The report can be purchased for all four pain types, or for one individual pain type only.
The report is intended to help pharmaceutical companies with products in this disease area get a deeper understanding of patient attitudes to chronic pain and the impact it has on patients’ lives, attitudes to HCP care and attitudes towards treatments received. It provides detailed information on patient pathways for each pain type.
Living with Chronic Pain is just one in a series of reports offering comprehensive insight into the chronic disease patient journey from pre-diagnosis to stabilisation. Living with Crohn’s (EU & US), Rheumatoid Arthritis (EU & US), Lupus (SLE) (EU and US), Ulcerative Colitis (EU) and PsA (EU) reports have been published this year and are available to purchase. Other therapy areas to be launched in 2017 include, Alzheimer’s, haemophilia, depression, and MS, amongst others.
More detailed findings from the study can be provided from Mariel Metcalfe on MarielM@researchpartnership.com